Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2022-04-28 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (58 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous or insufficient content documents.
2022-04-28 English
Book Closure
Regulatory Filings
2022-04-28 English
Record Date
Regulatory Filings Classification · 95% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement of a report. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2022-04-28 English
Investor Presentation
Regulatory Filings
2022-04-28 English
Press Release
Regulatory Filings
2022-04-28 English
Dividend
Regulatory Filings
2022-04-28 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.